Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05627128 · ClinicalTrials.gov registry record · NA
A Culturally Tailored Dietary Intervention to Treat Crohn's Disease
A NA study of Crohn Disease, sponsored by University of Massachusetts, Worcester.
- Active
- Registry status
- NA
- Development phase
- 150
- Enrollment target
- 2
- Study locations
NCT05627128: Active NA study of Crohn Disease, sponsored by University of Massachusetts, Worcester.
NCT05627128 is a NA study of Crohn Disease that is active but no longer recruiting, run by University of Massachusetts, Worcester. The registered enrollment target is 150 participants, below the 203-participant average among 71 other Crohn Disease trials with a reported enrollment target (26% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05627128, a NA study of Crohn Disease, is active but no longer recruiting, sponsored by University of Massachusetts, Worcester.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
- 2
- Study locations
Study Summary
The goal of the study is to test the efficacy of a dietary intervention in inducing clinical response and remission for patients with Crohn's disease in a randomized controlled trial. The intervention diet: DAIN has been adapted from the Inflammatory Bowel Disease Anti-Inflammatory Diet or IBD-AID™ taking into account the food availability and preferences of Puerto Ricans. DAIN also includes traditional foods commonly consumed in the typical Puerto Rican diet while maintaining the fundamental components of the IBD-AID™.
Primary Outcome
Improvement of health-related quality of life (increase of the short Inflammatory Bowel Disease Questionnaire score (SIBDQ)). The SIBDQ scores range between 10 and 70 points. A slightly impaired quality of life is indicated by scores from 60 to 70 points, moderately impaired quality of life from 45 to 60 points, and severely impaired quality of life from 10 to 45 points.
Conditions Studied
Interventions
- OTHER DAIN
Study Locations (2)
Massachusetts
- University of Massachusetts Chan MedicaL School - Worcester
Puerto Rico
- University of Puerto Rico - San Juan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2022-09-06 |
| Est. Completion | 2026-11-30 |
| Phase | NA |
What the registry record for NCT05627128 still lists
NCT05627128 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 203-participant average among 71 other Crohn Disease trials with a reported enrollment target (26% lower).
The record links to 1 condition, with Crohn Disease appearing as the primary indexed condition, and to 1 intervention - of which DAIN is the first listed.
NCT05627128 reports a single indexed study location in Massachusetts, Puerto Rico.
Frequently Asked Questions
What is clinical trial NCT05627128 about?
NCT05627128 is a clinical study titled "A Culturally Tailored Dietary Intervention to Treat Crohn's Disease". The goal of the study is to test the efficacy of a dietary intervention in inducing clinical response and remission for patients with Crohn's disease in a randomized controlled trial. The intervention diet: DAIN has been adapted from the Inflammatory Bowel Disease Anti-Inflammatory Diet or IBD-AID™ ...
What is the current status of trial NCT05627128?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2022-09-06. Estimated completion is 2026-11-30.
What conditions does trial NCT05627128 study?
This clinical trial studies the following conditions: Crohn Disease.
What interventions are being tested in trial NCT05627128?
The interventions under investigation include: DAIN (OTHER).
Who is sponsoring clinical trial NCT05627128?
This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05627128 being conducted?
This trial has 2 study locations across Massachusetts, Puerto Rico. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Crohn Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05627128's enrollment target sits among peer trials
150 27th of 71 higher than 45 of 71 other Crohn Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Crohn Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
RECRUITING · NA
-
Feasibility of a Wireless Thermal Capsule Endoscopy to Detect Gastrointestinal Thermal Variance
RECRUITING · NA
-
Personalized Risk Estimation for Crohn's Disease (PRE-Crohn's): Implementation and Feasibility
RECRUITING · NA
-
Impact of Prebiotics in Ulcerative Colitis
RECRUITING · NA
-
RISE: A Remote Study of Insomnia Treatment in Crohn's Disease
RECRUITING · NA
-
A Study for Imaging the Lower Gastrointestinal Tract Using a Retro-TCE Capsule
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI